GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sotera Health SHC · USD

Health Care · US listing · 🇺🇸 United States

Compare

16.44

+2.69%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$1.16bn

FY2018FY2025

Net income

$77.9m

FY2018FY2025

Free cash flow

$149.2m

FY2018FY2025

Shareholders' equity

$606.0m

FY2018FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue$1.16bn$1.10bn$1.05bn$1.00bn$931.5m$818.2m$778.3m$746.1m
Gross profit$645.5m$602.3m$577.2m$557.0m$518.7m$443.6m$395.4m$357.3m
Operating income$392.8m$297.6m$276.7m$248.3m$256.7m$206.0m$183.6m$80.8m
Net income$77.9m$44.4m$51.4m−$233.6m$116.9m−$38.6m−$20.9m−$5.9m
Diluted earnings per share0.270.160.18-0.830.42-0.15-0.07-0.03

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Total assets$3.26bn$3.07bn$3.13bn$3.12bn$2.79bn$2.76bn$2.58bn$2.71bn
Cash and short-term investments$346.5m$277.2m$296.4m$395.2m$106.9m$102.4m$62.9m$96.3m
Total liabilities$2.66bn$2.67bn$2.69bn$2.77bn$2.20bn$2.31bn$3.22bn$2.66bn
Debt$2.24bn$2.32bn$2.30bn$2.00bn$1.79bn$1.86bn$2.85bn$2.24bn
Shareholders' equity$606.0m$404.9m$443.7m$350.2m$586.1m$452.3m−$642.6m$44.4m
Shares outstanding286m285m283m280m280m253m279m232m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations$287.2m$224.2m−$147.7m$278.0m$281.5m$120.6m$149.0m$119.6m
Capital spending−$138.0m−$179.1m−$215.0m−$182.4m−$102.2m−$53.5m−$57.3m−$72.6m
Free cash flow$149.2m$45.1m−$362.7m$95.6m$179.4m$67.1m$91.8m$47.0m
Dividends paid—————−$150.0m−$691.2m−$175.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$321.4m$280.0m$303.4m$311.3m$294.3m$254.5m$290.2m$285.5m
Gross profit$178.0m$144.0m$165.9m$177.6m$166.6m$135.4m$164.4m$158.0m
Operating income$112.5m$86.6m$105.5m$112.1m$88.4m$57.0m$87.1m$80.5m
Net income$53.6m$26.6m$34.8m$48.4m$8.0m−$13.3m$12.3m$17.0m
Diluted earnings per share0.190.090.120.170.03-0.050.040.06
Cash from operations$88.0m$29.0m$103.0m$71.0m$57.0m$55.0m$55.0m$95.0m
Capital spending−$46.0m−$46.0m−$50.0m−$36.0m−$31.0m−$19.0m−$65.0m−$36.0m
Free cash flow$42.0m−$17.0m$53.0m$35.0m$26.0m$36.0m−$10.0m$59.0m
Total assets$3.31bn$3.24bn$3.26bn$3.19bn$3.22bn$3.10bn$3.07bn$3.15bn
Cash and short-term investments$356.7m$315.9m$346.5m$301.0m$332.4m$304.4m$277.2m$306.7m
Debt$2.15bn$2.15bn$2.15bn$2.15bn$2.23bn$2.23bn$2.23bn$2.23bn
Shareholders' equity$665.6m$622.5m$606.0m$550.5m$511.3m$414.1m$404.9m$470.2m

Financial ratios

Data as of 19 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin55.5%54.7%55.0%55.5%55.7%54.2%
Operating margin26.1%25.3%23.7%-16.2%26.8%21.6%
Net margin6.7%4.0%4.9%-23.3%12.5%-4.7%
Return on equity12.9%11.0%11.6%-66.7%19.9%-8.5%
Return on assets2.4%1.4%1.6%-7.5%4.2%-1.4%
Free cash flow yield8.3%7.9%1.3%9.2%7.7%3.8%
Revenue growth5.7%4.9%4.5%7.8%13.9%5.1%
Earnings growth75.6%-13.6%-122.0%-299.8%-402.7%85.2%
Current ratio2.46x2.75x2.42x0.81x2.15x2.24x
Debt to equity3.55x5.51x5.06x5.58x2.99x4.06x
Equity ratio18.6%13.2%14.2%11.2%21.0%16.4%
Interest coverage1.95x1.69x1.74x-2.03x3.37x0.82x
Buybacks as a share of market value-0.5%-0.6%-1.0%-0.2%-10.4%9.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.1%7.3%—
Operating income16.5%13.8%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin55.1%55.2%55.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings64.887.892.9-10.056.4-180.1
Price to sales4.33.54.52.37.18.5

Market value over time

30 Nov 2020 to 16 Oct 2026, in USD

$6.28bn$5.15bn

Share price return

Finished calendar years

202520242023202220212020
Return30%-20%99%-62%-16%6%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.